November 2010

ACT-AD to Host Alzheimer’s Allies Meeting on Streamlining Phase II Trials

ACT-AD, together with the Alzheimer’s Foundation of America, and the Alzheimer’s Drug Discovery Foundation, will host its third Alzheimer’s Allies meeting this month. The meeting will bring together researchers, clinicians, regulators, drug developers and advocacy groups to discuss challenges in recent Alzheimer’s disease drug development.  Expert presentations and panels will explore novel approaches to improving the way in which Phase II trials for disease-modifying therapies are designed in the future.

Confirmed speakers include:

  • Dr. Russell Katz, FDA – Director of the Division of Neurology Products
  • Dr. Rachelle Doody,Baylor College of Medicine – Professor of Neurology, Effie Marie Cain Chair in Alzheimer’s Research
  • Dr. Jeremy Hobart,Peninsula College of Medicine and Dentistry, United Kingdom – Senior Lecturer/Consultant Neurologist
  • Dr. Les Shaw,University ofPennsylvania – Professor of Pathology and Laboratory Medicine
  • Dr. Martin Farlow, Indiana University School of Medicine, Professor and Vice-Chair of Research in Neurology
  • Dr. Anthony Gamst,University ofCalifornia atSan Diego – Associate Professor, Division of Biostatistics and Neurosciences
  • Dr. Clifford Jack, Mayo Clinic – Professor of Radiology
  • Dr. Reisa Sperling, Harvard, Brigham and Women’s – Associate Professor of Neurology at Harvard Medical School and Director of Clinical Research at the Memory Disorders Unit at Brigham and Women’s Hospital
  • Dr. Dale Schenk, Elan Corporation – Executive Vice President and Chief Scientific Officer
  • Dr. Ronald Black, Pfizer – Assistant Vice President of Clinical Research and Development
  • Dr. Howard Feldman, Bristol-Myers Squibb – Vice President and Therapeutic Area Head of Global Clinical Research in Neuroscience
  • Dr. Rachel Schindler, Pfizer – Executive Director, Clinical Disease Area Expert Alzheimer’s Disease
  • Dr. Eric Siemers, Eli Lilly – Medical Director, Alzheimer’s Disease Research

For more information on the meeting, please contact Cynthia Bens at [email protected].

7 Summits Climb

On November 18, The 7 Summits Climb for Alzheimer’s: Memories are Everything campaign was launched, featuring Alzheimer’s advocate and alpine mountaineer Alan Arnette.

Alan is an alpine mountaineer embarking on an ambitious year-long expedition to climb the 7 highest peaks on each continent to raise awareness of the growing prevalence of Alzheimer’s and the enormous financial and personal burden it places on people with the disease, their caregivers and society. Through his efforts, Alan aims to show how the mental and physical challenges of scaling peaks are similar to the trials faced by people with Alzheimer’s and their caregivers.

Alan is dedicating this year-long campaign to his mother and two aunts who died from Alzheimer’s and the millions of others who are caring for people with the disease. Alan also hopes to inspire people to join his efforts to help raise $1 million to advance Alzheimer’s research. All funds raised will go directly to the organization Alan has selected – the Cure Alzheimer’s Fund™

GAO Appoints ACT-AD Member to CER Board

The Government Accountability Office announced this month that Gail Gibson Hunt, President and CEO of the National Alliance for Caregiving (NAC), has been appointed to the Patient-Centered Outcomes Research Institute Board of Governors(PCORI).  PCORI  was established as part of The Patient Protection and Affordable Care Act approved by the President  in March to establish priorities for and conduct of comparative effectiveness research in the United States.

Members of the PCORI Board of Governors are appointed by the Comptroller General to serve six-year terms. In selecting Ms. Hunt as one of the 19 Board of Governors, GAO has appointed a Board member who is a tireless advocate for caregivers and patients. She and the NAC were founding members of ACT-AD in 2004. We are pleased that she brings the diverse perspectives and knowledge of the needs of a complex population  to this important new institute.

To read more about PCORI, click here.